Zovighian said the transition to CEO has been relatively smooth since he joined Edwards in 2015 and spent eight years in ...
Hosted on MSN1d
Frail And Breathless At 94, Woman Overcomes Severe Breathlessness After Life-Saving Heart ProcedureTAVR (Transcatheter Aortic Valve Replacement) is a minimally invasive heart procedure that replaces a narrowed aortic valve ...
Edwards Lifesciences Corporation (NYSE:EW), a leading medical technology company specializing in heart valve therapies and critical care technologies with a market capitalization of $44.9 billion, has ...
Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this ...
TMTT sales surged 77% in 2023 to $352M, driven by PASCAL and EVOQUE adoption. TAVR sales reached $1.04B in Q4, up 5.3% ...
CHANDIGARH: 87 years old, Tara Chand (name changed), resident of Panchkula, had undergone a non-surgical procedure for aortic ...
Minimally invasive heart procedures like transcatheter aortic valve replacement (TAVR) and MitraClip placement to treat mitral regurgitation can improve quality of life, and even be lifesaving, for ...
Wise suggests that recent conversations with six Transcatheter aortic valve replacement (TAVR) physicians and a follow-up survey of thirty doctors support the view that TAVR growth could re ...
Edwards Lifesciences Corp.’s posted fourth quarter results slightly ahead of expectations, but indicated that the first quarter of 2025 might not be as bright. The company expects growth for both its ...
Reports Q4 revenue $1.39B, consensus $1.36B. Q4 TAVR sales grew 6%; constant currency sales grew 5%; Q4 TMTT sales grew 88% to $105 million ...
GlobalData’s latest report reveals that India accounted for only around 3 per cent of the market in APAC in 2024, due to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results